Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 214-161-1 | CAS number: 1103-39-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Studies on acute toxicity of the test item were not performed. Since all substances are metal laked salts with comparable structure and similar solubility, information on acute toxicity were derived from experimental data of a structural analogue. Five studies were performed to evaluate acute oral and inhalative toxicity of the test substance to the rat (according OECD 401 and 403). The test substance and the analogue did not induce mortalities, abnormalities or clinical signs when applied oral. Also single administration of the analogue substance via the respiratory system did not cause health effects or mortalities. The LD50 for oral toxicity is considered to be > 5000 mg/kg bw, LC50 is > 5.24 mg/l air.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: well documented, OECD guideline and GLP conform, read acros substance
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: HOECHST AG, Kastengrund, SPF breeding colony
- Age at study initiation: 7-8 weeks
- Weight at study initiation: 181-182 g
- Housing: groups of 5
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: not necessary (breeding at identical conditions)
- fasting period: from about 16 hours before to 3 - 4 hours after treatment
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 + /- 3
- Humidity (%): 55 +/- 20
- Air changes (per hr): fully air-conditioned rooms
- Photoperiod (hrs dark / hrs light): 12
- Route of administration:
- oral: gavage
- Vehicle:
- other: sesame oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 20 %
- Amount of vehicle (if gavage): 10 ml/kg body weight
MAXIMUM DOSE VOLUME APPLIED: 2000 mg/kg bw - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days 4
- Frequency of observations and weighing: Symptoms were recorded twice every day, weighed weekly
- Necropsy of survivors performed: yes - Statistics:
- not necessary
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Mortality:
- No deaths occurred during the whole study.
- Clinical signs:
- other: animals showed sunken flanks, stilted gait and squatting posture, all clinical signs of intoxication were reversible one day after application
- Gross pathology:
- The animals killed at the end of the observation period showed no macroscopically visible changes.
- Other findings:
- Additionally red colored feces was observed one day after application.
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- supporting study
- Study period:
- september 1978
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: very briefly documented; test substance is a mixture; almost no administrative data
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Principles of method if other than guideline:
- according H.F. Smyth et al (1962)
- GLP compliance:
- no
- Test type:
- other: Inhalations-Risiko-Test
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- source: Wiga, sulzfeld, Germany
food and water ad libitum - Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- whole body
- Vehicle:
- air
- Details on inhalation exposure:
- glassy inhalation chamber
substance enriched air (200 l/h) - Analytical verification of test atmosphere concentrations:
- no
- Duration of exposure:
- h
- Remarks on duration:
- 3, 10 and 30 min as well as 1, 3 and 7h
- Dose descriptor:
- other: mortality after inhalation
- Remarks on result:
- other: no mortalities after 7h inhalation
- Mortality:
- no
- Clinical signs:
- other: no signs of toxicity
- Gross pathology:
- without any findings
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 5.24 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Read across justification
Acute toxicity of the test substance was not examined. The test item shares structural similarity to analogue substances. All of them are metal laked salts and include 1 -amino-2 -naphthol which is connected via azo bond with an aromatic sulfonic acid. The salts are poor soluble in water and octanol and dissolve most likely in an acidic environment (e.g. stomach). Therefore, it is acceptable to derive information on acute toxicity from experimental data of the analogue substance.
Procedure and observations A single dose of 5000 mg/kg bw dissolved in PEG was administrated to a group of 10 rats (5/sex/dose) by gavage (Ciba 1975). After treatment animals were observed for 14d and checked for clinical signs. All animals survived until scheduled necropsy; abnormalities or signs of toxicity were not observed. The feces of the treated animals was red stained throughout the study.
Single doses (6000 and 10.000 mg/kg bw) of the analogue were administrated to groups of 10 male and 10 female rats by oral gavage (Ciba 1973). Following dosing, the animals were observed for 7d. There were no deaths as a result of treatment with the test article. Within 2 hours after treatment rats in both dosage groups showed dyspnoea, exophthalmus, curved position and ruffled fur. These symptoms became more accentuated as the dose was increased. The animals had recovered within 3 to 6 days.
Antoher acute oral toxicity study was conducted in 1993 (Hoechst). A single dose of 2000 mg/kg bw of a structural analogue was administrated to groups of 5 rats/sex by gavage. The animals were observed for 14 days and twice daily checked for clinical symptoms or mortalities. All animals survided until scheduled necropsy; gross necropsy did not reveal any findings. Symptoms like hunched posture or stilted gait resolved within 1 day. In addition, red stained feces was observed.
To evaluate the acute inhalative toxicity, male and female rats (5/sex/dose) were exposed for 4h to a dust aerosol of the analogue substance (range 4.25 - 6.33 mg/l air, nose only) (BASF 2010). Following dosing, the animals were observed for 14d. Examination of clinical signs and viability were performed daily, weighing on day 1, 7 and 13 after treatment. There were no deaths as a result of treatment with the test article. Clinical signs of toxicity or changes in body weight gain were not observed during the observation period. Gross necropsy was without any findings.
Similar results were determined in another inhalation study (Hoechst 1993). Animals (rats, 5/sex/dose) were exposed to dust (4.13 mg/l air, nose only) for 4h and observed for further 7 days. One male animal died accidentially during exposure; this death is not considered as treatment related. All other animals survided until scheduled necropsy; gross necropsy did not reveal any findings. Symptoms like irregular respiration, uncoordinated gait or trembling resolved within post observation period.
Discussion
Application of the test substance or an analogue via oral or inhalative route did not induce any signs of toxicity. None of the animals died due to treatment, viability and bodyweight gain were unaffected by the test article. The test item was not tested for acute dermal toxicity. With regard to the physico-chemical properties of the substance (pH, structure, solubility), the very limited skin penetration and the absence of systemic and local effects in acute oral and acute inhalation studies dermal toxicity is not likely.
Justification for classification or non-classification
Dangerous Substance Directive (67/548/EEC)
The available studies are considered reliable and suitable for classification purposes under 67/548/EEC. As a result the substance is not considered to be classified for acute toxicity under Directive 67/548/EEC, as amended for the 28th time in Directive 2001/59/EC.
Classification, Labelling, and Packaging Regulation (EC) No. 1272/2008
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance is not considered to be classified for acute toxicity under Regulation (EC) No. 1272/2008, as amended for the second time in Directive (EC 286/2011).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.